Catena Biosciences

Catena Biosciences is revolutionizing therapeutic development through its innovative protein coupling technology. Their platform enables the precise attachment of any two proteins, leveraging an enzyme and the naturally occurring amino acids tyrosine and cysteine found within the target proteins. This versatile technology overcomes limitations related to protein size and complexity, facilitating the creation of novel protein conjugates with minimal engineering. Catena's approach has already demonstrated its utility in modifying cancer-specific antibodies, CRISPR proteins, and even cell surfaces. By significantly accelerating the production of modular protein therapeutics, Catena empowers the creation of extensive libraries applicable across a broad spectrum of therapeutic areas, including oncology, vaccines, inflammatory diseases, and more.